These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 32251636

  • 1. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
    Wang H, Chen H, Jin J, Liu Q, Zhong D, Li G.
    Life Sci; 2020 Jun 15; 251():117638. PubMed ID: 32251636
    [Abstract] [Full Text] [Related]

  • 2. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice.
    Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G.
    Life Sci; 2019 Jun 15; 227():101-113. PubMed ID: 31002919
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.
    Hong P, Li FX, Gu RN, Fang YY, Lai LY, Wang YW, Tao T, Xu SY, You ZJ, Zhang HF.
    Neural Plast; 2018 Jun 15; 2018():9163521. PubMed ID: 29853850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.
    Ward R, Li W, Abdul Y, Jackson L, Dong G, Jamil S, Filosa J, Fagan SC, Ergul A.
    Pharmacol Res; 2019 Apr 15; 142():237-250. PubMed ID: 30818045
    [Abstract] [Full Text] [Related]

  • 8. NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke.
    Bellut M, Papp L, Bieber M, Kraft P, Stoll G, Schuhmann MK.
    Cell Death Dis; 2021 Dec 20; 13(1):20. PubMed ID: 34930895
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
    Zheng G, Xu J, He F, Hu J, Ge W, Ji X, Wang C, Bradley JL, Peberdy MA, Ornato JP, Toldo S, Wang T, Tang W.
    Biomed Pharmacother; 2021 Nov 20; 143():112093. PubMed ID: 34474352
    [Abstract] [Full Text] [Related]

  • 11. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
    Luo Y, Lu J, Ruan W, Guo X, Chen S.
    Brain Res Bull; 2019 Mar 20; 146():320-326. PubMed ID: 30716395
    [Abstract] [Full Text] [Related]

  • 12. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
    Zhao J, Guo X, Wang B, Yang Z, Huang T, Guo D, Zhang M, Song J.
    Neurochem Res; 2020 Sep 20; 45(9):2020-2031. PubMed ID: 32474832
    [Abstract] [Full Text] [Related]

  • 13. NLRP3 inflammasome inhibitor MCC950 reduces cerebral ischemia/reperfusion induced neuronal ferroptosis.
    Wu X, Wang B, Zhou Y, Yang Z, Jiang L, Kou Z, Li J, Ma X, Song J.
    Neurosci Lett; 2023 Jan 31; 795():137032. PubMed ID: 36581063
    [Abstract] [Full Text] [Related]

  • 14. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression.
    Wang S, Yao Q, Wan Y, Wang J, Huang C, Li D, Yang B.
    Int J Neurosci; 2020 Mar 31; 130(3):301-308. PubMed ID: 31607194
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM, Ling YH, Huuskes BM, Ferens DM, Saini N, Chan CT, Diep H, Kett MM, Samuel CS, Kemp-Harper BK, Robertson AAB, Cooper MA, Peter K, Latz E, Mansell AS, Sobey CG, Drummond GR, Vinh A.
    Cardiovasc Res; 2019 Mar 15; 115(4):776-787. PubMed ID: 30357309
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T, Yoshimatsu G, Sakata N, Kawakami R, Tanaka T, Yamada T, Yoshida Y, Hasegawa S, Kodama S.
    Sci Rep; 2020 Oct 21; 10(1):17920. PubMed ID: 33087823
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.